IDOC Releases Benchmark Report to Give Independent Practice Owners a Roadmap to Profitable Growth

IDOC’s third annual Benchmark Report, based on 175 independent U.S. optometry practices, says cost of goods sold and non-OD staff compensation have leveled off or declined after inflation-driven increases, while operating costs remain elevated. Its reference benchmarks are about 50% of collected revenue for COGS and non-OD staff, less than 20% for fixed costs, and over 30% for doctor pay and EBITDA; the report also says many practices may be under-investing in staff, space, and technology.

Analysis

This is weak, non-investable evidence about sector economics: an IDOC-sponsored sample may not represent the independent-practice universe, and the report’s “doctor pay and profits” bucket makes the >30% benchmark difficult to compare with EBITDA unless owner compensation is normalized consistently. The apparent easing in labor and product costs could stabilize practice-level margins, but it does not establish that reimbursement, patient volumes, or realized selling prices are improving. Persistent fixed-cost pressure and underinvestment instead favor operators that can spread administration, purchasing, and technology costs across more locations. That supports the relative position of scaled optical groups and consolidators over smaller stand-alone practices, while creating a potential opportunity for independent-practice service providers if owners act on the benchmarks. IDOC’s promotional claims are not evidence of subscription growth or financial materiality. Near term, likely negligible impact on public equities; over 6–18 months, the key question is whether independent owners invest to grow or become acquisition targets. The contrarian point: “under-spending” may be a sales framing, not proof that additional staff or technology earns attractive returns. Verify the sample’s size mix, owner-pay treatment, payer mix, and comparable historical data before extrapolating.

Key Decisions for Investors

• No directional trade on this release alone. Treat it as an industry watch item rather than a catalyst for optical retailers, vision-care providers, or suppliers.
• Over the next 1–3 months, monitor public optical retailers’ earnings commentary for evidence that independent-practice cost stabilization is affecting pricing, labor competition, or customer acquisition; absent such evidence, do not infer read-through from the benchmark.
• For a relative-value screen, compare scaled operators and consolidators with stand-alone practice exposure: the thesis is that shared overhead and purchasing scale matter more if fixed costs remain elevated. Do not initiate until company-level exposure and valuation are verified.
• Falsify the operating thesis if subsequent comparable data show renewed labor or product-cost inflation, or if practice revenue and collections weaken enough to absorb any cost relief. Seek independent sample details and normalized owner-compensation figures before using the report’s ratios in models.